King Agrees to Pay $124 Million to Settle Fraud Charges

Drug Industry Daily
KEYWORDS courts / FDA
A A

King Pharmaceuticals has agreed to pay roughly $124 million to settle state and federal charges that it underpaid rebates owed to Medicaid and other governmental pricing programs.

To View This Article:

Login

Subscribe To Drug Industry Daily